Fresenius SE KGaA (XTER:FRE) GF Value : €26.49 (As of May. 01, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-01), Fresenius SE KGaA's share price is €27.97. Fresenius SE KGaA's GF Value is €26.49. Therefore, Fresenius SE KGaA's Price-to-GF-Value for today is 1.06.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Fresenius SE KGaA is Fairly Valued.

Fresenius SE KGaA (XTER:FRE) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Fresenius SE KGaA's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	27.97	/	26.49
	=	1.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA GF Value Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius SE KGaA (XTER:FRE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

FSNUY:USA FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Executives

Dr. Michael Moser	Board of Directors
Sara Hennicken	Board of Directors
Michael Sen	Board of Directors
Dr. Francesco De Meo	Board of Directors
Stephan Sturm	Board of Directors
Wolfgang Kirsch	Supervisory Board
Mats Henriksson	Board of Directors
Dr. Gerd Krick	Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines